期刊文献+

ACA、TIMP-1、25(OH)D水平与急性脑梗死患者病情严重程度及预后的关系研究 被引量:8

Study on the relationship between the expression of ACA,TIMP-1,25(OH)D and the severity and prognosis of patients with ACI
下载PDF
导出
摘要 目的探究抗心磷脂抗体(ACA)、金属蛋白酶组织抑制因子1(TIMP-1)、25羟基维生素D[25(OH)D]水平与急性脑梗死(ACI)患者病情严重程度及预后的关系。方法选择2015年3月至2018年3月的334例ACI患者作为ACI组,选择同期体检健康者60例作为对照组。使用美国国立卫生研究院卒中量表评分按照患者病情严重程度将ACI患者分为轻度、中度和重度3组。根据神经功能恢复程度分析预后,并分析ACA、TIMP-1、25(OH)D水平与ACI患者病情严重程度及预后的关系。结果ACI组入院时血清中ACA和TIMP-1水平明显高于对照组,差异有统计学意义(P<0.05)。ACI组血清25(OH)D水平明显低于对照组,差异有统计学意义(P<0.05)。中度和重度患者血清ACA、TIMP-1水平明显高于轻度患者,重度患者血清ACA、TIMP-1明显高于中度患者,差异均有统计学意义(P<0.05)。中度和重度患者血清25(OH)D水平明显低于轻度患者,重度患者血清25(OH)D水平明显低于中度患者,差异均有统计学意义(P<0.05)。不同预后的患者血清ACA、TIMP-1、25(OH)D水平差异均有统计学意义(P<0.05),ACA和TIMP-1水平升高与较差的预后有关(P<0.05),而较低水平的25(OH)D与较差的预后有关(P<0.05)。结论ACI患者血清中ACA、TIMP-1水平升高,25(OH)D水平降低,并且高水平的ACA、TIMP-1和低水平的25(OH)D与更严重的病情和更差的预后有关。 Objective To explore the relationship between the expression of anticardiolipin antibody(ACA),tissue inhibitor of metalloproteinases 1(TIMP-1),25 hydroxyvitamin D[25(OH)D]and the severity and prognosis of patients with acute cerebral infarct(ACI).Methods A total of 334 patients with ACI from March 2015 to March 2018 were selected as the research subjects,60 healthy subjects were selected as control group.The NIH Stroke Scale score was used to classify ACI patients as mild,moderate,and severe according to their severity.The prognosis was analyzed according to the degree of neural function recovery.The relationship between the levels of ACA,TIMP-1,25(OH)D and the severity and prognosis of ACI patients were analyzed.Results The serum levels of ACA and TIMP-1 in the ACI group at admission were significantly higher than those in the control group,and the differences were statistically significant(P<0.05).The serum 25(OH)D level in the ACI group was significantly lower than that in the control group,and the difference was statistically significant(P<0.05).The levels of serum ACA and TIMP-1 in moderate and severe patients were significantly higher than those in mild patients,and the level of serum ACA and TIMP-1 in severe patients were significantly higher than those in moderate patients,and the differences were statistically significant(P<0.05).The serum 25(OH)D level in moderate and severe patients were significantly lower than that in the mild patients and the serum 25(OH)D level in the severe patients was significantly higher than that in the moderate patients,and the differences were statistically significant(P<0.05).There were significant differences in serum ACA,TIMP-1,25(OH)D levels in patients with different prognosis(P<0.05),the increase of ACA and TIMP-1 was associated with poor prognosis(P<0.05),lower levels of 25(OH)D was associated with poor prognosis(P<0.05).Conclusion The serum levels of ACA and TIMP-1 increase and 25(OH)D level decrease in ACI patients,and high levels of ACA,TIMP-1 and low level of 25(OH)D are associated with more severe disease and worse prognosis.
作者 刘美玲 许志伟 LIU Meiling;XU Zhiwei(Department of Emergency,the 909 Hospital of the Joint Service Support Force of the People′s Liberation Army,Zhangzhou,Fujian 363000,China)
出处 《国际检验医学杂志》 CAS 2020年第24期3007-3010,共4页 International Journal of Laboratory Medicine
关键词 急性脑梗死 抗心磷脂抗体 金属蛋白酶组织抑制因子1 25羟基维生素D acute cerebral infarct anticardiolipin antibody tissue inhibitor of metalloproteinases 1 25 hydroxyvitamin D
  • 相关文献

参考文献9

二级参考文献69

  • 1赵荣光,李戎,彭彩钰,牛亚南.从基质金属蛋白酶-3视角探索化纤系列方Ⅴ号方与艾灸防治肺纤维化的生物学机制[J].医学信息(医学与计算机应用),2014,0(10):493-493. 被引量:2
  • 2陈咸川,谢吟灵,吴晨,范代丽.益气活血化痰通络方治疗颈动脉硬化30例[J].陕西中医,2006,27(2):187-189. 被引量:20
  • 3周斌,李晓双,梁庆丰.颈动脉粥样硬化斑块及危险因素与脑梗死的关系[J].实用临床医学(江西),2006,7(8):35-38. 被引量:14
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 5Laloux P, Lemonnier F, Jamart J. Risk factors and treatment of stroke at the time of recurrence (- J . Acta Neurol Belg, 2010,110 (4) :299 - 302.
  • 6Cho SY, Oh CW, Bae HJ, et al. The prognostic factors that influ- ence long - term survival in acute large cerebral infarction [ J ]. J Korean Neurosurg Soc,2011,49 ( 2 ) : 92 - 96.
  • 7Ruiz IG, Cuadrado M J, Ruiz AI, et al. Evidence - based recommen- dations for the prevention and long - term management of thrombo- sis in antiphospholipid antibody - positive patients : report of a task force at the 13th International Congress on antiphospholipid anti- bodies[J]. Lupus,2011,20(2) :206 -218.
  • 8Artenjak A, Lakota K, Frank M, et al. Antiphospholipid antibodies as non- traditional risk factors in atherosclerosis based cardiovas- cular diseases without overt autoimmunity. A critical updated re-view[ J]. Autoimmun Rev,2012,11 (12) :873 - 882.
  • 9Devreese KM, Van HF. Anticardiolipin and anti - beta2 glycopro- tein - I antibody cut - off values in the diagnosis of antiphospholip- id syndrome : more than calculating the in - house 99th percertiles, even for new automated assays [ J . Thromb Res, 2011,128 ( 6 ) : 598 - 600.
  • 10Pengo V, Ruffatti A, Legnani C, et al. Incidence of a first thrombo- embolic event in asymptomatic earriem of high risk antiphospholip- id antibody profile: a multieenter prospective study [ ] ]. Blood, 2011 ,14(9) :178 - 181.

共引文献123

同被引文献65

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部